CanniMed, a trailblazer in the realm of medical cannabis, traces its roots back to the early 2000s when Prairie Plant Systems first introduced it as a brand dedicated to providing patients with safe and effective cannabis-based treatments. The term #1excludeGlossary cleverly combines “cannabis” and “medicine,” highlighting its primary mission to serve the medical community. Over the years, CanniMed has become a symbol of trust and quality in the cannabis industry, known for its commitment to research, development, and patient care. As the landscape of cannabis continues to shift, CanniMed remains at the forefront, adapting to new regulations and patient needs while maintaining its core values. This adaptability has cemented CanniMed’s position as a leader in the medical cannabis field, offering hope and healing to countless individuals. For further reading, check out resources like [MedPub](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/) and [Harvard Health](https://www.health.harvard.edu/blog/medical-marijuana-2018011513085).
CanniMed Therapeutics Inc. is a Canadian public licensed producer of medical cannabis. It is primarily focused on cannabis oil. The company's predecessor, Prairie Plant Systems, was established in 1988 and is located in Saskatoon, Saskatchewan. In 2013 CanniMed became the first cannabis producer to be licensed under Health Canada regulations that were issued that year. It went public in 2016, and in March 2018 almost all of its stock was acquired by a rival producer, Aurora Cannabis, following a hostile takeover to which company management finally consented.
 | |
| Company type | Subsidiary |
|---|---|
| TSX: CMED | |
| Industry | Medical Cannabis |
| Founded | 1988 |
| Founder | Brent Zettl |
| Headquarters | , |
Area served | Canada |
| Products | Medical cannabis |
| Parent | Aurora Cannabis |
| Website | |